Summary
52 / 100 · Bulios Score
What speaks for it
- It holds more cash than debt: $34.8M against $28.8M.
- It earns 17 USD a year on every 100 USD of invested capital.
What to watch
- The company made a loss over the last 12 months.
- Operating profit does not even cover the interest on its debt.
- The share price is above the Bulios Fair Price.
- It passes only 2 of the 9 points of the Piotroski financial health test.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
The company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
SlowlyRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 5.2% a year over 5 years. Over the last 3 years it grew by 4.7% a year.
Growth in detailDoes it make money?
PoorlyOver the last 12 months it made a loss of $3.28M.
Profitability in detailIs it financially healthy?
YesRepaying all its debt would take 1.6 years of free cash flow. It holds more cash than debt.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 5
- Hold 1
- Sell 0
Today's price within the analysts' price targets
The average target of $4.25 is 108% above today's price. 83% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
The company reports no revenue by product.
By region
- INDIA 34%
- North America 33%
- EMEA 14%
- Latin America 8.9%
- Asia Pacific 8.6%
- Other 1.1%
INDIA brings in 34% of revenue. North America grew fastest, by 24% a year.
Segments in detail